Mycophenolate mofetil is compatible with CD28/CD154 costimulatory blockade in preventing transplant rejection.
Vu
Minh Diem
MD
Li
Yongsheng
Y
Strom
Terry B
TB
Li
Xian Chang
XC
D000818:Animals; D018106:CD28 Antigens / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D023201:CD40 Ligand / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D049109:Cell Proliferation / Q000187:drug effects; D006084:Graft Rejection / Q000276:immunology* / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology; D051379:Mice; D023421:Models, Animal; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology*; D016038:Skin Transplantation / Q000276:immunology
D018106:CD28 Antigens; D023201:CD40 Ligand; D009173:Mycophenolic Acid